Successful treatment of severe refractory folliculitis decalvans and lichen planopilaris phenotypic spectrum with baricitinib.

Olumiant (baricitinib) - Eli Lilly

Successful treatment of severe refractory folliculitis decalvans and lichen planopilaris phenotypic spectrum with baricitinib. (PubMed, Eur J Dermatol) - Sep 7, 2026 - No abstract available
Journal • Lichen Planus

http://www.ncbi.nlm.nih.gov/pubmed/42702027

Carlo Pipitò; Chiara Quitadamo; Emiliano Antiga; Maria Efenesia Baffa; Roberto Maglie; Sasha Visinoni; Stefano Colabrese; Vincenzina Rubino

Sep 7, 2026